Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex proteins. Improving these processes involves modifying various factors, including cell line engineering, media formulation, and bioreactor conditions. A key goal is to increase antibody production while lowering production expe